Get in Touch

Reach out to our team for assistance with your legal and regulatory needs.

Table of Contents

February 2025


OFW’s Cannabis Team regularly monitors cannabis news, legislation, regulation, and policy so our clients stay up-to-date on the latest developments impacting their business.


If you have any questions or would like more information about any of the items below, please contact us.


We also track cannabis-related legislation introduced in the U.S. Congress.  If you would like to learn more about our Congressional Bill Tracker, please reach out to Ben Dash


Executive Branch/Enforcement

  • Department of the Air Force memorandum states that no individual may use, possess, distribute, or introduce marijuana on bases.
  • President Donald Trump is promoting his support for executing people who sell currently illicit drugs, calling it a “very humane” policy to prevent overdose deaths that he’s “ready” to implement.
  • Cannabis Industry Cautiously Optimistic Over RFK Jr’s appointment, but controversial figure remains double edged sword
  • Doctors for Drug Policy Reform (D4DPR) ask the US Appellate Court for redo in DEA’s selections for cannabis rescheduling participants, arguing the DEA’s selections were arbitrary and capricious, providing ‘cure letters’ as evidence of ex parte communications.

U.S. Congress

  • Rep. Brian Mast (R-FL-21) reintroduced the Veterans Equal Access Act to allow government healthcare providers to recommend medical cannabis.
  • Rep. Greg Steube (R-FL-17) reintroduced legislation, the Veterans Cannabis Use for Safe Healing Act, which aims to prohibit the VA from denying veteran benefits because of participation in a state-approved cannabis program.
  • Rep. Jodey Arrington (R-TX-19), chair of the House Budget Committee, filed a bill that would continue to block marijuana businesses from taking federal tax deductions under Internal Revenue Service (IRS) code 280E, even if cannabis is federally rescheduled.
  • Sen. John Fetterman’s campaign (D-PA) is promoting the senator’s pro-marijuana legalization platform, urging people to sign a petition to show “just how much support he has on this issue.”
  • Rep. Dina Titus (D-NV-1) tweeted, “As Co-Chair of the Cannabis Caucus, I am grateful to have @CPIatUNLV as a resource in my district. I joined a roundtable they hosted to discuss cannabis research, the future of the industry, and the potential for reform at the state and federal level.”
  • The issue of marijuana-impaired driving arose again at congressional hearing last week, with a representative of the Governors Highway Safety Association emphasizing the importance of roadside drug testing as a tool to help combat deadly car crashes.

The States

Cannabis Abroad

  • Costa Rica: The Ministry of Health approved a new regulation that will facilitate the sale of medical cannabis products to help patients who urgently need them to treat their health conditions. 
  • Canada: Statistics Canada released December retail sales for the country, with cannabis sales increasing from the November levels, up 10.0% to a record C$499.7 million; Cannabis Data Gathering Program: A comparison of legal and illegal dried cannabis products
  • New Zealand: Industrial hemp regulation review gets the green light
  • Nambia: High Court to hear case on whether cannabis ban in Namibia is unconstitutional

Business, Banking, Insurance

  • Inside Cannabis’ $2 Billion Crash: MedMen’s Collapse Was ‘A Smoke And Mirrors Show,’ Says Ousted CEO In Upcoming Memoir
  • MMJ’s innovative soft gelatin THC-CBD capsule, known as MMJ-002, is undergoing the rigorous FDA approval process to validate the safety and efficacy of cannabis-derived therapeutics for use in human clinical trials for Huntington’s disease patients.

Research

Other Noteworthy Updates

  • Exploring the Crossroads of Cannabis and Psychiatry: As cannabis transitions from an illicit drug to a multi-billion-dollar industry, psychiatry faces both challenges and opportunities in exploring its therapeutic potential while balancing the risks.
  • Visiting the DEA Museum: “My excuse was to see all the lies and misinformation in one place.”

***

If you are interested in exploring commercial opportunities in the cannabis space, we would be happy to assist you in any of your cannabis law questions, comments, or concerns. Please contact Tish Pahl ([email protected]), Kyla Kaplan ([email protected]), Denise Calle ([email protected]), and Ben Dash ([email protected]) for assistance.

Disclaimer: The content provided on this blog is intended for general informational and educational purposes only and does not constitute legal advice. The information presented by OFW Law is not intended to create, and receipt or viewing does not constitute, an attorney-client relationship. While we strive to provide accurate and timely information regarding our practice areas, laws and regulations change frequently; therefore, we cannot guarantee that all information is current or applicable to your specific situation. You should not act or refrain from acting on the basis of any content included in this site without seeking the appropriate legal or other professional advice on the particular facts and circumstances at issue from an attorney licensed in your state. All liability with respect to actions taken or not taken based on the contents of this site is hereby expressly disclaimed.